High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9.

Shounak MajumderWilliam R TaylorPatrick H FooteCalise K BergerChung Wah WuDouglas W MahoneyWilliam R BamletKelli N BurgerNeil PostierJaime de la Fuente Karen A DoeringGraham P LidgardHatim T AllawiGloria M PetersenSuresh T ChariDavid A AhlquistJohn B Kisiel

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Plasma MDMs in combination with CA19-9 detect PDAC with significantly higher accuracy compared with either biomarker individually.

Keyphrases

high throughput
circulating tumor
protein kinase
cell free
label free
nucleic acid
circulating tumor cells